ArticleOncology and therapy2025

Evaluation of Event-Free Survival as a Surrogate Endpoint for Overall Survival in Muscle-Invasive Bladder Cancer Following Neoadjuvant Treatment: A Systematic Review and Meta-Analysis.

Cora N Sternberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.